Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Quimbaya Gold Closes C$14.4 Million Bought Deal Financing November 4, 2025 Gold Miners Ride Record Prices to Strong Q3 Results November 4, 2025 FPX Nickel November 3, 2025